Argitalpenak (84) Estíbaliz Alegre Martínez argitalpenak

2024

  1. Clinical utility of personalized reference intervals for CEA in the early detection of oncologic disease

    Clinical Chemistry and Laboratory Medicine

  2. Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories

    Critical Reviews in Clinical Laboratory Sciences, Vol. 61, Núm. 6, pp. 435-457

  3. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

  4. Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294

2023

  1. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma

    Clinica Chimica Acta, Vol. 548

  2. MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. PSA reactivity in extracellular microvesicles to commercial immunoassays

    Clinica Chimica Acta, Vol. 543

2022

  1. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes

    Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 7, pp. 1003-1010

  2. Modification of baseline status to improve breath tests performance

    Scientific Reports, Vol. 12, Núm. 1

  3. Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough

    Clinical chemistry, Vol. 68, Núm. 9, pp. 1128-1132

2021

  1. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

    Cytokine, Vol. 141

  2. Exosomes in lung cancer: Actors and heralds of tumor development

    Cancers, Vol. 13, Núm. 17

  3. mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 207-219

2020

  1. Estudio del test de tolerancia a lactosa como alternativa a test de hidrógeno espirado en el estudio de la malabsorción de lactosa

    Advances in Laboratory Medicine, Vol. 1, Núm. 4

  2. Lactose tolerance test as an alternative to hydrogen breath test in the study of lactose malabsorption

    Advances in Laboratory Medicine, Vol. 1, Núm. 4

  3. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients

    Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348

  4. Realización de pruebas innecesarias en los ensayos clínicos: HCG como ejemplo

    Advances in Laboratory Medicine

  5. Unnecessary test ordering in clinical trials: Human chorionic gonadotropin as an example

    Advances in Laboratory Medicine

  6. Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal

    Advances in Laboratory Medicine, Vol. 1, Núm. 1

  7. Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

    Advances in Laboratory Medicine, Vol. 1, Núm. 1